He holds a degree in General Pharmacy from the Faculdade de Imperatriz (2012), a Master’s degree in Pharmaceutical Sciences (drugs and medicines) from the Federal University of Goiás (2015), and a PhD in Biological Sciences (Pharmacology and Physiology) from the same institution (2015–2019). He has experience in Medicinal Pharmaceutical Chemistry, focusing on the synthesis of new substances with potential pharmacological activity, under the supervision of Prof. Dr. Ricardo Menegatti (Coordinator of the Medicinal Pharmaceutical Chemistry Laboratory—LQFM—at the Federal University of Goiás School of Pharmacy). He is currently an Adjunct Professor/Researcher (Level I) at the State University of Tocantins (Nursing program) and at CEUMA University (Nursing and Medicine programs). He founded the research group LQMS (Medicinal and Synthetic Chemistry Laboratory), where he conducts research focusing on the *in silico* design and synthesis of new antitumor agents (inhibitors of MDM2 and MDM4 proteins), cyclooxygenase enzyme inhibitors (COX-1 and COX-2), and acetylcholinesterase inhibitors for Alzheimer's treatment. His work also includes the design of TrkB agonists (BDNF analogs) to stimulate neurogenesis, the development of dual-action drug candidates (hypoglycemic and antioxidant) for Type 2 Diabetes Mellitus, and the design, synthesis, and repurposing of drugs targeting neglected diseases.
He holds a degree in General Pharmacy from the Faculdade de Imperatriz (2012), a Master’s degree in Pharmaceutical Sciences (drugs and medicines) from the Federal University of Goiás (2015), and a PhD in Biological Sciences (Pharmacology and Physiology) from the same institution (2015–2019). He has experience in Medicinal Pharmaceutical Chemistry, focusing on the synthesis of new substances with potential pharmacological activity, under the supervision of Prof. Dr. Ricardo Menegatti (Coordinator of the Medicinal Pharmaceutical Chemistry Laboratory—LQFM—at the Federal University of Goiás School of Pharmacy). He is currently an Adjunct Professor/Researcher (Level I) at the State University of Tocantins (Nursing program) and at CEUMA University (Nursing and Medicine programs). He founded the research group LQMS (Medicinal and Synthetic Chemistry Laboratory), where he conducts research focusing on the *in silico* design and synthesis of new antitumor agents (inhibitors of MDM2 and MDM4 proteins), cyclooxygenase enzyme inhibitors (COX-1 and COX-2), and acetylcholinesterase inhibitors for Alzheimer's treatment. His work also includes the design of TrkB agonists (BDNF analogs) to stimulate neurogenesis, the development of dual-action drug candidates (hypoglycemic and antioxidant) for Type 2 Diabetes Mellitus, and the design, synthesis, and repurposing of drugs targeting neglected diseases.